Search - tctmd.com

Displaying 241 - 260 of 394

Sort: Relevancy | Date

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

May 22, 2018

Seattle Angina Questionnaire Works Equally Well in Women

News Daily News

Seattle Angina Questionnaire Works Equally Well in Women

Michael O'Riordan

April 30, 2018

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

News Conference News SCAI 2018

ORBITA Continues to Surprise: 85% of Sham Arm Opted for PCI When Trial Ended

April 26, 2018

Remaining Active After MI May Help Stave Off Mortality

News Daily News

Remaining Active After MI May Help Stave Off Mortality

April 23, 2018

$Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina$

News Daily News

Positive Real-World Results for Coronary Sinus Reducer in Patients With Refractory Angina

April 16, 2018

For CHD Patients, Physical Activity More Meaningful Than Weight Changes Over Time

News Daily News

For CHD Patients, Physical Activity More Meaningful Than Weight Changes Over Time

March 13, 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

News Conference News ACC 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

March 11, 2018

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

Obesity Robs People of CVD-Free Years and Ups the Risk of Dying Young

News Daily News

Obesity Robs People of CVD-Free Years and Ups the Risk of Dying Young

Michael O'Riordan

March 02, 2018

Smartphone App May Help Acute MI Survivors Stay Out of the Hospital

News Daily News

Smartphone App May Help Acute MI Survivors Stay Out of the Hospital

February 22, 2018

Compliance With Preventive Drugs After CABG, PCI Found Lacking in Clinical Trials

News Daily News

Compliance With Preventive Drugs After CABG, PCI Found Lacking in Clinical Trials

February 06, 2018

AHA Releases Scientific Statement on Breast Cancer and CVD

News Daily News

AHA Releases Scientific Statement on Breast Cancer and CVD

February 01, 2018

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

News Daily News

High Rate of Clinical Events at 6 Months for Ischemic CVD Patients

Michael O'Riordan

January 19, 2018

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

News Daily News

Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis

January 08, 2018

Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II

News Daily News

Myocardial Perfusion Imaging May Enhance CT-Based Evaluation of Stable Angina: CRESCENT II

December 15, 2017

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

November 22, 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

News Conference News AHA 2017

Missed by Risk Calculators, Few Young MI Patients Were Previously on Statins

November 14, 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.